Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rena M Conti

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Pharmacoepidemiology and Drug Safety|September 30, 2014
Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescentsRobert D Gibbons, Marcelo Coca Perraillon, Kwan Hur, et al.
Health Services Research|November 13, 2007
Using performance data to identify preferred hospitalsMeredith B Rosenthal, Mary Beth Landrum, Ellen Meara, et al.
JAMA Health Forum|July 3, 2025
Cost-Sharing and Buprenorphine Prescription DispensingThuy D Nguyen, Rena M Conti, Pooja Lagisetty, et al.
Journal of General Internal Medicine|June 18, 2024
Association Between Cost-Sharing and Buprenorphine Prescription AbandonmentKao-Ping Chua, Rena M Conti, Pooja Lagisetty, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2012
Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisoryStacie B Dusetzina, Alisa B Busch, Rena M Conti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologistsRena M Conti, Arielle C Bernstein, Victoria M Villaflor, et al.
The New England Journal of Medicine|April 24, 2024
Buprenorphine Dispensing after Elimination of the Waiver RequirementKao-Ping Chua, Mark C Bicket, Amy S B Bohnert, et al.
Journal of Oncology Practice|March 5, 2015
Reply to M. Thompson et AlBlase Polite, Jeffery C Ward, John V Cox, et al.
Journal of Oncology Practice|May 14, 2016
A Pathway Through the Bundle JungleBlase Polite, Jeffery C Ward, John V Cox, et al.
Medical Care|April 23, 2013
The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancerRena M Conti, Stacie B Dusetzina, Ann C Herbert, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Pharmacoepidemiology and Drug Safety|September 30, 2014
Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescentsRobert D Gibbons, Marcelo Coca Perraillon, Kwan Hur, et al.
Health Services Research|November 13, 2007
Using performance data to identify preferred hospitalsMeredith B Rosenthal, Mary Beth Landrum, Ellen Meara, et al.
JAMA Health Forum|July 3, 2025
Cost-Sharing and Buprenorphine Prescription DispensingThuy D Nguyen, Rena M Conti, Pooja Lagisetty, et al.
Journal of General Internal Medicine|June 18, 2024
Association Between Cost-Sharing and Buprenorphine Prescription AbandonmentKao-Ping Chua, Rena M Conti, Pooja Lagisetty, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2012
Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisoryStacie B Dusetzina, Alisa B Busch, Rena M Conti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologistsRena M Conti, Arielle C Bernstein, Victoria M Villaflor, et al.
The New England Journal of Medicine|April 24, 2024
Buprenorphine Dispensing after Elimination of the Waiver RequirementKao-Ping Chua, Mark C Bicket, Amy S B Bohnert, et al.
Journal of Oncology Practice|March 5, 2015
Reply to M. Thompson et AlBlase Polite, Jeffery C Ward, John V Cox, et al.
Journal of Oncology Practice|May 14, 2016
A Pathway Through the Bundle JungleBlase Polite, Jeffery C Ward, John V Cox, et al.
Medical Care|April 23, 2013
The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancerRena M Conti, Stacie B Dusetzina, Ann C Herbert, et al.
Pageof 14